Hypercell Technologies has developed a proprietary point-of-care diagnostic platform that delivers PCR-level accuracy in detecting biological contaminants in the food chain, achieving results ten times faster than traditional methods. This technology addresses the significant economic losses and health risks associated with infectious diseases in production animals and food-borne illnesses affecting consumers.
Funding
Funding not disclosed
PAFounders
Product
Problem
Infectious diseases in production animals lead to significant economic losses and potential zoonotic threats. Current diagnostic methods for foodborne illnesses either lack accuracy for early detection or require lengthy lab processing, hindering timely intervention and response.
Solution
Hypercell Technologies offers a rapid, point-of-care diagnostic platform for detecting biological contaminants throughout the food chain. Their technology achieves PCR-level accuracy in a fraction of the time compared to traditional lab-based methods, enabling early identification and management of threats. By eliminating the need for expensive equipment and specialized personnel, Hypercell facilitates frequent and precise testing at the source, from production to transformation. This allows for quicker response times, reduced contamination risks, and improved food safety.
Target Audience
The primary customers are stakeholders in the food chain, including production animal farmers, food processors, and quality control personnel responsible for ensuring food safety.
Features
- Proprietary point-of-care diagnostic platform delivering PCR-level accuracy
- 10x faster results compared to traditional qPCR methods
- Enables rapid detection of biological contaminants in the food chain
- Eliminates the need for expensive lab equipment and specialized staff
- Facilitates frequent and precise testing at the source